MedPath

A randomised controlled trial of TF-CBT in South African adolecents

Phase 1
Conditions
Mental and Behavioural Disorders
Registration Number
PACTR202011506380839
Lead Sponsor
Debra Kaminer
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Other
Sex
All
Target Recruitment
84
Inclusion Criteria

Participants must have been exposed to a traumatic event according to the DSM 5 PTSD Criterion A.

Participants must meet criteria for a clinical or subclinical diagnosis of PTSD according to the DSM-5, as assessed using the KSADS-PL and the CPSS-5. Subclinical PTSD is defined as having at least 1 re-experiencing symptom, at least 2 avoidance symptoms, 2 arousal symptoms and/or a score of at least 21 on the CPSS-5. Adolescents with both acute (1-3 months post-trauma) and chronic (>3 months post-trauma) PTSD will be included into the study, given that the evidence for TF-CBT shows benefit for both acute and chronic groups.

Provided that PTSD is the primary disorder requiring treatment, adolescents with comorbid mood disorders, anxiety disorders, substance use disorders and behavioural disorders (of oppositional defiant disorder, conduct disorder or and attention-deficit/hyperactivity disorder) and sub-clinical substance misuse will be included.

At least six years of formal education.

Proficiency in English or Afrikaans.

Exclusion Criteria

Intellectual disability or autism spectrum disorder
Psychotic disorder
High suicide risk
Clinically significant alcohol or substance abuse

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath